{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:11:25Z","timestamp":1790230285609,"version":"4.1.0"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Tauopathies are neurodegenerative diseases, including Alzheimer\u2019s disease (AD) and frontotemporal dementia (FTD), in which tau protein aggregates within neurons. An effective treatment is lacking and is urgently needed. We evaluated two structurally similar natural compounds, morin and resveratrol, for treating tauopathy in JNPL3 P301L mutant human tau overexpressing mice. Rotarod tests were performed to determine effects on motor function. After treatment from age 11 to 14 months, brains of 26 mice were collected to quantify aggregated hyperphosphorylated tau by Thioflavin T and immunohistochemistry (IHC) and to quantify total tau (HT7 antibody) and hyperphosphorylated tau (AT8 antibody) in homogenates and a fraction enriched for paired helical filaments. Resveratrol reduced the level of total hyperphosphorylated tau in IHC sections (p=0.036), and morin exhibited a tendency to do so (p=0.29), while the two drugs tended to increase the proportion of solubilizable tau that was hyperphosphorylated, as detected in blots. Neither resveratrol nor morin affected motor function. One explanation of these results is that the drugs might interrupt a late stage in tau aggregation, after small aggregates have formed but before further aggregation has occurred. Further animal studies would be informative to explore the possible efficacy of morin or resveratrol for treating tauopathies.<\/jats:p>","DOI":"10.1515\/tnsci-2018-0010","type":"journal-article","created":{"date-parts":[[2018,11,11]],"date-time":"2018-11-11T09:11:23Z","timestamp":1541927483000},"page":"54-60","source":"Crossref","is-referenced-by-count":35,"title":["Effects of resveratrol and morin on insoluble tau in tau transgenic mice"],"prefix":"10.1515","volume":"9","author":[{"given":"Kwun Chung","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley K.K.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref201","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","year":"2005","journal-title":"Science"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresrev.2006.04.004","article-title":"Resveratrol--a boon for treating Alzheimer\u2019s disease?","volume":"52","year":"2006","journal-title":"Brain Res Rev"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies","volume":"8","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2202-9-S2-S6","article-title":"Therapeutic potential of resveratrol in Alzheimer\u2019s disease","volume":"9","year":"2008","journal-title":"BMC Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-Synaptic Spread of Tau Pathology In Vivo","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression","volume":"286","year":"2011","journal-title":"J Biol Chem"},{"key":"ref51","first-page":"a006437","article-title":"Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets","volume":"1","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M508246200","article-title":"Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","year":"2000","journal-title":"Nat Genet"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12031-011-9566-7","article-title":"Are tangles as toxic as they look?","volume":"45","year":"2011","journal-title":"J Mol Neurosci"},{"key":"ref21","volume-title":"Rang and Dale\u2019s Pharmacology","year":"2007"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2011.07.005","article-title":"Morin attenuates tau hyperphosphorylation by inhibiting GSK3beta","volume":"44","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11357-012-9489-4","article-title":"Dietary resveratrol prevents Alzheimer\u2019s markers and increases life span in SAMP8","volume":"35","year":"2013","journal-title":"Age (Dordr)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mcna.2013.01.002","article-title":"Clinical trials in predementia stages of Alzheimer disease","volume":"97","year":"2013","journal-title":"Med Clin North Am"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease","volume":"54","year":"2009","journal-title":"Neurochem Int"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/09637486.2013.832171","article-title":"Resveratrol increases cerebral glycogen synthase kinase phosphorylation as well as protein levels of drebrin and transthyretin in mice: an exploratory study","volume":"65","year":"2014","journal-title":"Int J Food Sci Nutr"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of alpha-synuclein filament assembly","volume":"45","year":"2006","journal-title":"Biochemistry (NY)"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","article-title":"Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain","volume":"69","year":"2001","journal-title":"Life Sci"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/j.1460-2075.1992.tb05204.x","article-title":"The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region","volume":"11","year":"1992","journal-title":"EMBO J"}],"container-title":["Translational Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/tnsci.2018.9.issue-1\/tnsci-2018-0010\/tnsci-2018-0010.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2018-0010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T04:44:58Z","timestamp":1619066698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2018-0010\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":22,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1515\/tnsci-2018-0010","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]}}}